公司介紹
研究內容
新聞中心
營運目標
聯絡我們
ZH
ZH
EN
公司介紹
研究內容
新聞中心
營運目標
聯絡我們
研發核心技術
開發平台
作用機制
研究時程
Indication
Program
Discovery
Prexlinical
Phase1
Phase2
Phase3
Rights
FEC205
Pancreatic cancer
FEC1040
Liver cancer
FEC1057
Colorectal cancer
研發成果: 國際期刊發表
📘
Effects of Resistant-Starch-Encapsulated Probiotic Cocktail on Intestines Damaged by 5-Fluorouracil
Authors:
Wang JL, Yeh CH, Huang SH, Wu LS, Chen MC
Journal:
Biomedicines
Publication Date:
August 2024
Volume / Issue / Pages:
Vol. 20, Issue 8, Page 1912
DOI:
10.3390/biomedicines12081912
PMID:
39200376
Access:
Free PMC Article
📘
Resistant Starch-Encapsulated Probiotics Attenuate Colorectal Cancer Cachexia and 5-Fluorouracil-Induced Microbial Dysbiosis
Authors:
Wang JL, Yeh CS, Huang KC, Yeh CH, Chen MC, Wu LS, Chiu YH
Journal:
Biomedicines
Publication Date:
August 2024
Volume / Issue / Pages:
Vol. 20, Issue 8, Page 1450
DOI:
10.3390/biomedicines12081450
PMID:
39062024
Access:
Free PMC Article
© Fecula Biotech. All Rights Reserved.
Website constructed by
澄交生技 Fecula Biotech
06-505-0511
service@fecula.com.tw
744092台南市新市區南科三路25號4樓之1A